List of insiders holdings for FIVE PRIME THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2021-03-08 16:58:17 | 6,262,085 0 | 6,262,085 | Form 3 |
| ADAGE CAPITAL PARTNERS GP LLC Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 2018-02-13 16:06:29 | 1,300,000 0 | 1,300,000 | Form 13G |
| Williams Lewis T Director | 2019-09-04 13:20:35 | 455,336 0 | 455,336 | Form 4 |
| Knickerbocker Aron Marc President & CEO | 2019-09-04 13:18:46 | 42,057 200,299 | 242,356 | Form 4 |
| Hambleton Julie EVP & Chief Medical Officer | 2015-11-13 17:04:38 | 137,201 1,764 | 138,965 | Form 4 |
| Wong Brian Russell SVP, Research | 2015-06-24 17:11:45 | 117,464 0 | 117,464 | Form 3 |
| Sikorski Robert Steven SVP and Chief Medical Officer | 2017-03-03 13:36:16 | 104,158 0 | 104,158 | Form 4 |
| Baker Kevin Paul SVP, Development Sciences | 2018-02-28 19:23:08 | 98,184 0 | 98,184 | Form 4 |
| Belsky Marc Senior Vice President and CFO | 2018-02-28 19:24:47 | 34,314 44,158 | 78,472 | Form 4 |
| Borges Luis SVP, Research | 2017-03-03 13:29:09 | 64,888 0 | 64,888 | Form 4 |
| Irving Bryan EVP, Chief Scientific Officer | 2019-05-16 18:29:24 | 30,533 0 | 30,533 | Form 4 |
| Douglas R Lee Director | 2016-10-13 13:02:19 | 1,220 15,642 | 16,862 | Form 4 |
| Kavanaugh William Michael SVP & Chief Scientific Officer | 2014-08-26 17:15:48 | 15,000 0 | 15,000 | Form 4 |
| ATWOOD BRIAN G Director | 2015-06-16 17:16:31 | 12,500 0 | 12,500 | Form 4 |
| MCDADE MARK Director | 2018-05-14 20:18:30 | 10,000 0 | 10,000 | Form 4 |
| Gujrathi Sheila Director | 2018-05-14 18:47:39 | 10,000 0 | 10,000 | Form 4 |
| Cohen Fred E Director | 2017-05-12 16:20:32 | 10,000 0 | 10,000 | Form 4 |
| Sarena Francis Willard Chief Strategy Officer | 2021-04-19 20:04:26 | 0 0 | 0 | Form 4 |
| Smith David V Executive Vice President & CFO | 2021-04-19 19:57:02 | 0 0 | 0 | Form 4 |
| Collins Helen Louise EVP and Chief Medical Officer | 2021-04-19 19:53:58 | 0 0 | 0 | Form 4 |
| White David See Remarks | 2021-04-19 19:49:04 | 0 0 | 0 | Form 4 |
| RINGO WILLIAM R Director | 2021-04-19 19:46:08 | 0 0 | 0 | Form 4 |
| BERGER FRANKLIN M Director | 2021-04-19 19:42:33 | 0 0 | 0 | Form 4 |
| Dhingra Kapil Director | 2021-04-19 19:39:43 | 0 0 | 0 | Form 4 |
| Jensen Peder Director | 2021-04-19 19:35:28 | 0 0 | 0 | Form 4 |
| Nicholson Garry A Director | 2021-04-19 19:32:22 | 0 0 | 0 | Form 4 |
| SCHAFER CAROL Director | 2021-04-19 19:28:40 | 0 0 | 0 | Form 4 |
| Lyons-Williams Lori Director | 2021-04-19 19:25:16 | 0 0 | 0 | Form 4 |
| Civik Thomas President and CEO | 2021-04-19 19:21:50 | 0 0 | 0 | Form 4 |
| PFIZER INC 10% Owner | 2016-02-11 17:27:13 | 0 0 | 0 | Form 13G |
| Rubinstein Linda M Interim CFO | 2018-04-23 13:29:46 | 0 0 | 0 | Form 3 |